quinidine has been researched along with Asymmetric Diabetic Proximal Motor Neuropathy in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Olney, N; Rosen, H | 1 |
Hepner, A; Pope, LE; Shaibani, AI; Thisted, R | 1 |
Berg, JE; Culligan, NW; Gerard, G; Klaff, L; Pope, LE; Schwartz, SL; Thisted, RA; Wymer, JP | 1 |
1 review(s) available for quinidine and Asymmetric Diabetic Proximal Motor Neuropathy
Article | Year |
---|---|
AVP-923, a combination of dextromethorphan hydrobromide and quinidine sulfate for the treatment of pseudobulbar affect and neuropathic pain.
Topics: Animals; Clinical Trials as Topic; Dextromethorphan; Diabetic Neuropathies; Drug Combinations; Humans; Mood Disorders; Quinidine | 2010 |
2 trial(s) available for quinidine and Asymmetric Diabetic Proximal Motor Neuropathy
Article | Year |
---|---|
Efficacy and safety of dextromethorphan/quinidine at two dosage levels for diabetic neuropathic pain: a double-blind, placebo-controlled, multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Dextromethorphan; Diabetic Neuropathies; Double-Blind Method; Drug Combinations; Excitatory Amino Acid Antagonists; Female; Humans; Male; Middle Aged; Placebos; Quinidine | 2012 |
Dextromethorphan and quinidine in adult patients with uncontrolled painful diabetic peripheral neuropathy: a 29-day, multicenter, open-label, dose-escalation study.
Topics: Adult; Aged; Analgesics, Opioid; Chromatography, Liquid; Dextromethorphan; Diabetic Neuropathies; Dose-Response Relationship, Drug; Female; Humans; Male; Mass Spectrometry; Middle Aged; Pain; Quinidine | 2006 |